«Glycated Haemogloin, Fasting Plasma Glucose, Plasminogen Activator Inhibitor Type-1, and Soluble Thrombomodulin Levels in Patients with Type 2 Diabetes Mellitus», NJPS, vol. 36, n.º 2, pp. 159–164, dic. 2021, doi: 10.54548/njps.v36i2.3.